APA (7th ed.) Citation

Giaginis, C., Damaskos, C., Koutsounas, I., Zizi-Serbetzoglou, A., Tsoukalas, N., Patsouris, E., . . . Theocharis, S. (2015). Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: Associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Gastroenterology, 15, 1. https://doi.org/10.1186/s12876-015-0379-y

Chicago Style (17th ed.) Citation

Giaginis, Constantinos, Christos Damaskos, Ioannis Koutsounas, Adamantia Zizi-Serbetzoglou, Nicolaos Tsoukalas, Efstratios Patsouris, Gregorios Kouraklis, and Stamatios Theocharis. "Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Human Pancreatic Adenocarcinoma: Associations with Clinicopathological Parameters, Tumor Proliferative Capacity and Patients' Survival." BMC Gastroenterology 15 (2015): 1. https://doi.org/10.1186/s12876-015-0379-y.

MLA (9th ed.) Citation

Giaginis, Constantinos, et al. "Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Human Pancreatic Adenocarcinoma: Associations with Clinicopathological Parameters, Tumor Proliferative Capacity and Patients' Survival." BMC Gastroenterology, vol. 15, 2015, p. 1, https://doi.org/10.1186/s12876-015-0379-y.